Despite flat overall Q2 2025 sales, Keytruda's continued strong performance in oncology supports long-term bullish prospects ...

Beginning this October, HCSO’s program “will provide Sublocade, a long-acting monthly injection designed to support ...

Gain a competitive edge at this premier event featuring technical education, networking and exhibits to spur innovation and ...

Campbell has been assigned a six-month contract to ‘drive forward solutions’ in the community hard-hit by the overdose crisis ...

The injection is currently only offered in hospitals at the time of birth, and is designed to protect the newborns during ...

An initiative of the Manufacturing Institute, which is the workforce development and education affiliate of the National ...

Right to free speech that is foundational to our existence as a democratic republic are not the purview of those in good ...

"It has been challenging to realise the journey from drug delivery concepts to effective formulations containing the right drug loading, but recent reproducible in vitro results at VALLAURIX have ...

Today, Novo Nordisk announced Mim8 (denecimig) has been submitted for review to the US Food and Drug Administration (FDA) ...

Most organizations now recognize the transformative power of Generative AI. They also understand its risks. The next step is ...

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-T) from The Globe and Mail including charting and trades.

HOUSTON, TX / ACCESS Newswire / September 30, 2025 / EON Resources Inc. (NYSE American:EONR) (“EON” or the “Company”) is an ...